Ohio Revised Code Search
Section |
---|
Section 5164.60 | Interest on Medicaid provider excess payments.
...Any medicaid provider who, without intent, obtains payments under the medicaid program in excess of the amount to which the provider is entitled is liable for payment of interest on the amount of the excess payments for a period determined by the department, but not to exceed the period from the date on which payment was made to the date on which repayment is made to the state. The interest shall be paid at the avera... |
Section 5164.61 | Scope of available remedies for recovery of excess payments.
... a county department of job and family services to recover excess medicaid payments made to a medicaid provider is not limited by the availability of remedies under sections 5162.21 and 5162.23 of the Revised Code for recovering benefits paid on behalf of medicaid recipients. |
Section 5164.70 | Limitations on medicaid payments for services.
...n, no medicaid payment for any medicaid service provided by a hospital, nursing facility, or ICF/IID shall exceed the limits established under Subpart C of 42 C.F.R. Part 447. |
Section 5164.71 | Payments for freestanding medical laboratory charges.
...Medicaid payments for freestanding medical laboratory charges shall not exceed the customary and usual fee for laboratory profiles. |
Section 5164.72 | Limitations on payments for inpatient hospital care.
...The number of days of inpatient hospital care for which a medicaid payment is made on behalf of a medicaid recipient to a hospital that is not paid under a diagnostic-related-group prospective payment system shall not exceed thirty days during a period beginning on the day of the recipient's admission to the hospital and ending sixty days after the termination of that hospital stay, except that the department of medi... |
Section 5164.721 | Claims by freestanding birthing centers.
...A hospital or freestanding birthing center that is a medicaid provider may submit to the department of medicaid or the department's fiscal agent a medicaid claim that is both of the following: (A) For a long-acting reversible contraceptive device that is covered by medicaid and provided to a medicaid recipient during the period after the recipient gives birth in the hospital or center and before the recipient is di... |
Section 5164.73 | Division of payments between physician or podiatrist and nurse.
...e, or certified nurse practitioner for services performed by the nurse shall be determined and agreed on by the nurse and collaborating physician or podiatrist. In no case shall the medicaid payment exceed the medicaid payment that the physician or podiatrist would have received had the physician or podiatrist provided the entire service. |
Section 5164.74 | Reimbursement of graduate medical education costs.
...ducation costs associated with medicaid services rendered to medicaid recipients. Subject to section 5164.741 of the Revised Code, the rules shall provide for payment of graduate medical education costs associated with medicaid services rendered to medicaid recipients, including recipients enrolled in a medicaid managed care organization, that the department of medicaid determines are allowable and reasonable. |
Section 5164.741 | Payment for graduate medical education costs to noncontracting hospitals.
...ssociated with the delivery of medicaid services to any medicaid recipient if the hospital refuses without good cause to contract with a medicaid managed care organization that serves the area in which the hospital is located. (B) A hospital is not subject to division (A) of this section if all of the following are the case: (1) The hospital is located in a county in which participants in the care management ... |
Section 5164.75 | Medicaid payment for a drug subject to a federal upper reimbursement limit.
...As used in this section, "federal upper reimbursement limit" means the limit established pursuant to the "Social Security Act," section 1927(e), 42 U.S.C. 1396r-8(e). The medicaid payment for a drug that is subject to a federal upper reimbursement limit shall not exceed, in the aggregate, the federal upper reimbursement limit for the drug. |
Section 5164.751 | State maximum allowable cost program.
...(A) As used in this section, "state maximum allowable cost" means the per unit amount the medicaid program pays a terminal distributor of dangerous drugs for a prescribed drug included in the state maximum allowable cost program established under division (B) of this section. "State maximum allowable cost" excludes dispensing fees and copayments, coinsurance, or other cost-sharing charges, if any. (B) Subject to se... |
Section 5164.752 | Determining maximum dispensing fee.
...ect prescription expenses, professional services and personnel costs, and usual and customary overhead expenses of the terminal distributors surveyed. The survey shall compute and report the cost of dispensing by terminal distributors. |
Section 5164.753 | Dispensing fee.
...In December of every even-numbered year, the medicaid director shall establish dispensing fees, effective the following July, for terminal distributors of dangerous drugs that are providers of drugs under the medicaid program. In establishing dispensing fees, the director shall take into consideration the results of the survey conducted under section 5164.752 of the Revised Code. The director may establish dispensing... |
Section 5164.754 | Agreement for multiple-state drug purchasing program.
...(A) As used in this section, "dangerous drug" and "manufacturer of dangerous drugs" have the same meaning as in section 4729.01 of the Revised Code. (B) The medicaid director may enter into or administer an agreement or cooperative arrangement with other states to create or join a multiple-state prescription drug purchasing program for the purpose of negotiating with manufacturers of dangerous drugs to receiv... |
Section 5164.755 | Supplemental drug rebate program.
...ent in the provider's primary place of business. If the director establishes a supplemental drug rebate program, the director shall consult with drug manufacturers regarding the establishment and implementation of the program. |
Section 5164.756 | Drug rebate agreement or supplemental drug rebate agreement for medicaid program not subject to public records law.
...Any record, data, pricing information, or other information regarding a drug rebate agreement or a supplemental drug rebate agreement for the medicaid program that the department of medicaid receives from a pharmaceutical manufacturer or creates pursuant to negotiation of the agreement is not a public record under section 149.43 of the Revised Code and shall be treated by the department as confidential informa... |
Section 5164.757 | E-prescribing applications.
...(A) As used in this section, "licensed health professional authorized to prescribe drugs" has the same meaning as in section 4729.01 of the Revised Code. (B) The medicaid director may acquire or specify technologies to provide information regarding medicaid recipient eligibility, claims history, and drug coverage to medicaid providers through electronic health record and e-prescribing applications. If such te... |
Section 5164.758 | Adoption of rules for implementation of coordinated services program for medicaid users who abuse prescription drugs.
...evised Code to implement a coordinated services program for medicaid recipients who are found to have obtained prescribed drugs under the medicaid program at a frequency or in an amount that is not medically necessary. The program shall be implemented in a manner that is consistent with the "Social Security Act," section 1915(a)(2), 42 U.S.C. 1396n(a)(2), and 42 C.F.R. 431.54(e). |
Section 5164.759 | Outpatient drug use review program.
...In accordance with the "Social Security Act," section 1927(g), 42 U.S.C. 1396r-8(g), the department of medicaid shall establish an outpatient drug use review program to assure that prescriptions obtained by medicaid recipients are appropriate, medically necessary, and unlikely to cause adverse medical results. |
Section 5164.7510 | Pharmacy and therapeutics committee.
...(A) There is hereby established the pharmacy and therapeutics committee of the department of medicaid. The committee shall assist the department with developing and maintaining a preferred drug list for the medicaid program. The committee shall review and recommend to the medicaid director the drugs that should be included on the preferred drug list. The recommendations shall be made based on the evaluation of comp... |
Section 5164.7511 | Medication synchronization for medicaid recipients.
...ation synchronization" means a pharmacy service that synchronizes the filling or refilling of prescriptions in a manner that allows the dispensed drugs to be obtained on the same date each month. (3) "Prescriber" has the same meaning as in section 4729.01 of the Revised Code. (B) With respect to coverage of prescribed drugs, the medicaid program shall provide for medication synchronization for a medicaid recipient ... |
Section 5164.7512 | Definitions for sections 5164.7512 to 5164.7514.
... determine whether or not a health care service or drug is appropriate and consistent with medical or scientific evidence. (3) "Medical or scientific evidence" has the same meaning as in section 3922.01 of the Revised Code. (4) "Step therapy exemption" means an overriding of a step therapy protocol in favor of immediate coverage of a medicaid provider's selected prescription drug. (5) "Step therapy protocol" m... |
Section 5164.7514 | Step therapy exemption process.
...urs for requests related to urgent care services; (b) Ten calendar days for all other requests. (2)(a) If an exemption request is denied, a medicaid provider may appeal the denial on behalf of the medicaid recipient. (b) From the time a step therapy appeal is received, the department shall either grant or deny the appeal within the following time frames: (i) Forty-eight hours for appeals related to urgent ... |
Section 5164.7515 | Annual benchmark for prescribed drug spending growth.
...(A) Not later than July 1, 2020, the medicaid director shall establish an annual benchmark for prescribed drug spending growth under the medicaid program. If the director determines that prescribed drug spending in a given year is projected to exceed the benchmark for that year, the director shall identify specific prescribed drugs that significantly contribute to exceeding the benchmark. (B) For a prescribed drug ... |
Section 5164.76 | Manner of payment for community mental health service providers or facilities and alcohol and drug addiction services.
...medicaid: (1) Community mental health service providers or facilities for providing community mental health services covered by the medicaid program pursuant to section 5164.15 of the Revised Code; (2) Providers of alcohol and drug addiction services for providing alcohol and drug addiction services covered by the medicaid program. (B) The director's authority to modify the manner, or to establish a new mann... |